Alterations in T cell subsets in human immunodeficiency virus-infected adults with co-infections in southern Mozambique

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 4, 2011, Pages 776-781

  Naniche, Denise ^a   Letang, Emilio ^a,b   Nhampossa, Tacilta ^b,c   David, Catarina ^b,c   Menendez, Clara ^a,b   Alonso, Pedro ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Manhiça Health Research Center   (Mozambique)

^c INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; L SELECTIN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEMALE; HEPATITIS B; HEPATITIS C; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MEMORY CELL; MIXED INFECTION; MOZAMBIQUE; SCREENING; SEROPREVALENCE; SYPHILIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MOZAMBIQUE; T-LYMPHOCYTE SUBSETS;

HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; PLASMODIUM FALCIPARUM;

EID: 80053898069     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0713     Document Type: Article

References (23)

1. Lawn SD, 2004. AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J Infect 48: 1-12. (Pubitemid 38072197)
2. Giorgi JV, Lyles RH, Matud JL, Yamashita TE, Mellors JW, Hultin LE, Jamieson BD, Margolick JB, Rinaldo CR Jr, Phair JP, Detels R, 2002. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 29: 346-355. (Pubitemid 34288887)
3. Pandrea I, Sodora DL, Silvestri G, Apetrei C, 2008. Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts. Trends Immunol 29: 419-428.
4. Eggena MP, Barugahare B, Okello M, Mutyala S, Jones N, Ma Y, Kityo C, Mugyenyi P, Cao H, 2005. T cell activation in HIVseropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection. J Infect Dis 191: 694-701. Epub 2005 Jan 31.
5. Kassu A, Tsegaye A, Petros B, Wolday D, Hailu E, Tilahun T, Hailu B, Roos MT, Fontanet AL, Hamann D, De Wit TF, 2001. Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales. Clin Diagn Lab Immunol 8: 1171-1176. (Pubitemid 33035751)
6. Messele T, Abdulkadir M, Fontanet AL, Petros B, Hamann D, Koot M, Roos MT, Schellekens PT, Miedema F, Rinke de Wit TF, 1999. Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin Exp Immunol 115: 443-450. (Pubitemid 29130358)
7. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, 1995. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 95: 2061-2066.
8. Letang E, Almeida JM, Miro JM, Ayala E, White IE, Carrilho C, Bastos R, Nhampossa T, Menendez C, Campbell TB, Alonso PL, Naniche D, 2010. Predictors of immune reconstitution inflammatory syndrome-associated with Kaposi sarcoma in Mozambique: a prospective study. J Acquir Immune Defic Syndr 53: 589-597.
9. Bhatt NB, Gudo ES, Sema C, Bila D, Di Mattei P, Augusto O, Garsia R, Jani IV, 2009. Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients. Int J STD AIDS 20: 863-868.
10. Brites C, Sampalo J, Oliveira A, 2009. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev 11: 8-16.
11. Gudo ES, Bhatt NB, Bila DR, Abreu CM, Tanuri A, Savino W, Silva-Barbosa SD, Jani IV, 2009. Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS? BMC Infect Dis 9: 211.
12. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, Hamann D, Prins M, Miedema F, 2003. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17: 1881-1888. (Pubitemid 37070273)
13. Sodora DL, Silvestri G, 2008. Immune activation and AIDS pathogenesis . AIDS 22: 439-446. (Pubitemid 351317285)
14. Brenchley JM, Hill BJ, Ambrozak DR, Price DA, Guenaga FJ, Casazza JP, Kuruppu J, Yazdani J, Migueles SA, Connors M, Roederer M, Douek DC, Koup RA, 2004. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol 78: 1160-1168. (Pubitemid 38095826)
15. Buchacz K, Patel P, Taylor M, Kerndt PR, Byers RH, Holmberg SD, Klausner JD, 2004. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 18: 2075.
16. Brites C, Alencar R, Gusmao R, Pedroso C, Netto EM, Pedral- Sampaio D, Badaro R, 2001. Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil. AIDS 15: 2053-2055. (Pubitemid 32982162)
17. Lawn SD, Butera ST, Folks TM, 2001. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 14: 753-777. (Pubitemid 32979630)
18. 3reduces immune activation with no effect on HIV load or CD4 count. PLoS ONE 5: e9138.
19. Kovacs A, Al-Harthi L, Christensen S, Mack W, Cohen M, Landay A, 2008. CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus. J Infect Dis 197: 1402-1407. (Pubitemid 351706464)
20. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, Deeks SG, 2003. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 187: 1534-1543. (Pubitemid 36578959)
21. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD, 2009. Effect of early versus deferred antiretroviral therapy for HIV on survival . N Engl J Med 360: 1815-1826.
22. Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, Dabis F, Miro JM, Justice AC, Ledergerber B, Fatkenheuer G, Hogg RS, Monforte AD, Saag M, Smith C, Staszewski S, Egger M, Cole SR, 2009. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373: 1352-1363.
23. Kovacs A, Karim R, Mack WJ, Xu J, Chen Z, Operskalski E, Frederick T, Landay A, Voris J, Spencer LS, Young MA, Tien PC, Augenbraun M, Strickler HD, Al-Harthi L, 2010. Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis 201: 823-834.